Immediate Impact
5 from Science/Nature 53 standout
Citing Papers
Thyroid cancer
2023 Standout
O -GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation
2023 Standout
Works of Laura Esserman being referenced
Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.
2017
Ductal Carcinoma In Situ
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Laura Esserman | 496 | 246 | 251 | 30 | 874 | |
| Dieter Lampe | 401 | 535 | 324 | 32 | 1.0k | |
| Penny J. Barnes | 333 | 261 | 125 | 44 | 823 | |
| Sandra S. Hatch | 311 | 369 | 135 | 53 | 798 | |
| Maja Primic‐Žakelj | 623 | 141 | 194 | 36 | 1.1k | |
| Olorunsola F. Agbaje | 428 | 251 | 169 | 26 | 930 | |
| Tamera J. Lillemoe | 441 | 162 | 92 | 28 | 1.0k | |
| Elizabeth M. Azzato | 377 | 349 | 72 | 41 | 919 | |
| Katherine E. Posther | 413 | 389 | 178 | 16 | 1.1k | |
| Ashu Gandhi | 348 | 475 | 88 | 49 | 1.1k | |
| Chris I. Flowers | 398 | 333 | 238 | 22 | 1.0k |
All Works
Loading papers...